Advertisement

5 Responses

  1. The Fickle Future of Faster & Generic Insulins | Knowledge of Medicine

    [...] post The Fickle Future of Faster &Generic Insulins appeared first on DiabetesMine:the all things diabetes [...]

  2. Amanda
    Amanda June 12, 2013 at 6:21 am | | Reply

    Thanks for the article. I also live in Greenwood but have not even heard of Elona Biotechnologies. Perhaps because my daughter was just diagnosed last year.

  3. Mike Errigo
    Mike Errigo June 12, 2013 at 7:04 am | | Reply

    Here is a link to an article describing a new type of enzyme being developed by Halozyme Therapeutics (www.halozyme.com) that helps insulin absorb quicker, act sooner, and leave the body faster without altering the structure of the insulin itself. You take it in conjunction with insulin and it alters the structure of the skin, allowing insulin to absorb faster, with no lasting effects. The enzyme itself has already cleared the FDA for use in other applications (they are working on moving certain therapies from intravenous to subcutaneous). This is promising and may possibly be in the near future.
    http://insulinnation.com/faster-insulin-extracellular-action/

  4. Chloe Chase
    Chloe Chase June 13, 2013 at 10:12 am | | Reply

    Thank you for this important update on generics. The diabetes community needs to put greater focus on this issue.

  5. Bernard Farrell
    Bernard Farrell June 24, 2013 at 1:52 pm | | Reply

    Generics can’t come soon enough.

    I just learned from CVS Caremark that Humalog is now off-formulary (not covered). Can’t use Apidra in pumps, so my only other choice is Novolog which is a big unknown for me. Diabetes and insurance is never a good mix.

Leave a Reply